Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Getting access to the new hep C drugs remains an ongoing barrier for too many people, but the drugs keep getting better.
Merck’s investigational hepatitis C treatment grazoprevir/elbasvir cured high rates of the virus among individuals coinfected with HIV.
Individuals who have failed hepatitis C treatment may ultimately achieve a cure if they add Sovaldi (sofosbuvir) to a subsequent treatment reg...
Drinking coffee is linked with reduced liver fibrosis among people with hepatitis B, hepatitis C, and non-alcoholic fatty liver disease.
Twelve or 16 weeks of Sovaldi (sofosbuvir) and ravidasvir cured high rates of people with genotype 4 of hepatitis C virus in a recent large tr...
Sovaldi and velpatasvir, with/without ribavirin, yielded good results among people with various genotypes of HCV and decompensated cirrhosis
Gilead Sciences Sovaldi (sofosbuvir) and velpatasvir posted near-perfect results in curing an array of genotypes of hepatitis C.
8 weeks of Harvoni (ledipasvir/sofosbuvir) and vedroprevir boasted a near-perfect cure rate among those with genotype 1 and advanced liver dis...
Daklinza (daclatasvir) and Sovaldi (sofosbuvir) more effectively cures hepatitis C among those coinfected with HIV than does Sovaldi and...
Those with advanced fibrosis or cirrhosis who are cured of hepatitis C often experience regression of liver damage, improving by at least one...
Long time health advocate Bill Remak’s reflections on the 2015 AASLD Liver Meeting and hepatitis C advocacy
AbbVie’s investigational hepatitis C treatments ABT-493 and ABT-530 posted mostly high cure rates among people with genotypes 2 and 3.
Eight or 12 weeks of AbbVie’s investigational hepatitis C treatments ABT-493 and ABT-530 cured 97 to 100 percent of people with genotype 1.
A nucleic acid-based polymer called REP 2139, given alone and with interferon, has shown promise treating coinfection with hep B and hep D.
The high success rate of today’s hepatitis C treatments may keep many people from needing a liver transplant.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.